URALYT-U Price

Overview

Welcome to Dwaey, specifically on URALYT-U page.
This medicine contains an important and useful components, as it consists of
Hexapotassium - Hexasodium Pentacitrate Hydrate Complexis available in the market in concentration

Name

Mebendazole

Precaution

Before initiating **Mebendazole**, it is critical that patients consult with their healthcare provider to determine whether this medication is appropriate for their specific condition and health profile. Several key precautions should be considered: - **Pregnancy**: **Mebendazole** is classified as a **Category C** medication during pregnancy. Although animal studies have shown some adverse effects, there is insufficient human data. **Mebendazole** should only be used during pregnancy if absolutely necessary and if the potential benefits outweigh the risks, especially in the first trimester. It is contraindicated during pregnancy unless the benefit to the mother justifies the potential risk to the fetus. - **Liver Function**: Caution is advised in patients with **liver dysfunction**, as **Mebendazole** is metabolized in the liver. In patients with liver impairment, the drug may accumulate in the body, leading to an increased risk of side effects. Liver function should be monitored periodically during treatment. - **Pre-existing Conditions**: Patients with a history of **intestinal obstruction** or **malabsorption syndromes** should be carefully monitored when using **Mebendazole**, as these conditions could affect the drug's absorption and efficacy. - **Drug Interactions**: **Mebendazole** may interact with other drugs, especially those that affect liver enzymes (e.g., **cimetidine**, **phenytoin**, or **carbamazepine**). The interaction could alter the metabolism of **Mebendazole** and lead to toxicity or reduced efficacy. - **Breastfeeding**: **Mebendazole** is excreted in breast milk. While it is unlikely to affect a nursing infant, **consultation with a healthcare provider** is advised to determine the risks and benefits of using **Mebendazole** during lactation. - **Children**: Caution should be exercised when administering **Mebendazole** to children, especially those under the age of 2, due to potential side effects or insufficient safety data.

Indication

**Mebendazole** is an **anthelmintic medication** primarily used to treat various parasitic worm infections. Its therapeutic indications include: - **Pinworm Infections (Enterobiasis)**: **Mebendazole** is widely used to treat infections caused by **Enterobius vermicularis** (pinworms), which are common in children. - **Roundworm Infections (Ascariasis)**: It is effective in treating **Ascariasis**, an infection caused by **Ascaris lumbricoides**, a large intestinal worm. - **Hookworm Infections**: **Mebendazole** can be used for the treatment of infections caused by **Ancylostoma duodenale** and **Necator americanus**, which are hookworms that reside in the intestines. - **Whipworm Infections (Trichuriasis)**: It is also prescribed for treating infections caused by **Trichuris trichiura**, or whipworms, that can affect the large intestine. - **Other Parasitic Infections**: **Mebendazole** is also used for infections caused by other helminths like **strongyloides**, **taenia**, and **filarial** worms in some regions. It is important to note that **Mebendazole** is specifically used for **intestinal parasitic infections** and is not effective for infections caused by **external parasites** such as lice or scabies.

Contra indication

**Mebendazole** should not be used in the following situations: - **Hypersensitivity**: Patients with a known hypersensitivity to **Mebendazole** or any of its components should avoid using this medication to prevent allergic reactions. - **Severe Liver Disease**: **Mebendazole** is metabolized in the liver, and patients with **severe liver disease** (e.g., cirrhosis or active liver failure) should not use **Mebendazole** or should do so under careful medical supervision, with potential dose adjustments or alternative treatments. - **Pregnancy (First Trimester)**: **Mebendazole** should be avoided during the first trimester of pregnancy due to potential risks to the fetus. If treatment is necessary, it should be prescribed with caution and under the strict supervision of a healthcare provider. - **Children under 2 years**: The use of **Mebendazole** is contraindicated in children under 2 years old due to a lack of sufficient safety data in this age group. - **Intestinal Obstruction**: Patients with **intestinal obstruction** should avoid using **Mebendazole** as the medication may not be effectively absorbed in these conditions.

Side Effect

Like all medications, **Mebendazole** can cause side effects, although not everyone will experience them. The common and serious side effects include: - **Gastrointestinal Disturbances**: The most common side effects of **Mebendazole** are related to the digestive system and include **nausea**, **vomiting**, **diarrhea**, and **abdominal pain**. These symptoms are usually mild and transient. - **Headache and Dizziness**: Some patients may experience **headache** or **dizziness** during treatment with **Mebendazole**. - **Rash and Pruritus**: **Mebendazole** can cause an allergic skin reaction in some patients, leading to **rash** or **itching**. - **Liver Toxicity**: Rarely, **Mebendazole** may cause liver damage, which could present as **yellowing of the skin or eyes (jaundice)**, **dark urine**, or **persistent abdominal pain**. Regular monitoring of liver function is recommended during prolonged use. - **Hair Loss (Alopecia)**: **Mebendazole** has been associated with **hair loss** in some patients, but this is usually reversible upon discontinuation of the drug. - **Bone Marrow Suppression**: In rare cases, **Mebendazole** may cause **bone marrow suppression**, resulting in **anemia**, **leukopenia**, or **thrombocytopenia**, which can increase the risk of infections or bleeding. Blood counts should be monitored if signs of this occur. Serious side effects are rare, but patients should seek immediate medical attention if they experience any signs of **liver damage** or unusual **hematological changes**.

Pregnancy Category ID

3

Mode of Action

**Mebendazole** is an **anthelmintic** medication, primarily acting by interfering with the metabolism of parasitic worms. Its mechanism of action is as follows: - **Inhibition of Microtubule Formation**: **Mebendazole** works by binding to **beta-tubulin** in the cells of the worms, preventing the formation of microtubules. Microtubules are essential for the normal function of the worm’s intestinal cells, and their disruption leads to the immobilization and eventual death of the parasite. - **Inhibition of Glucose Uptake**: By disrupting microtubule formation, **Mebendazole** also inhibits the **absorption of glucose** by the parasite. Without glucose, the worm cannot produce energy, leading to its eventual death. - **Localized Effect**: The drug primarily acts within the intestines, where it remains concentrated, making it effective in treating intestinal worm infections. It is poorly absorbed into the bloodstream, which minimizes systemic effects. This unique action helps to eliminate a wide range of parasitic infections, especially **intestinal helminths**, such as **pinworms**, **roundworms**, and **hookworms**.

Interaction

Several drugs and substances may interact with **Mebendazole**, affecting its efficacy or causing harmful side effects: - **Cimetidine**: **Cimetidine**, a medication used to treat acid reflux, can inhibit the liver enzymes responsible for metabolizing **Mebendazole**, potentially increasing its concentration in the body and increasing the risk of toxicity. - **Phenytoin and Carbamazepine**: These anticonvulsants may reduce the blood levels of **Mebendazole** by inducing liver enzymes that break down the drug, potentially reducing its effectiveness. - **Albendazole**: When used together with **Albendazole**, there may be a cumulative effect on the liver, increasing the risk of **hepatotoxicity**. - **Warfarin**: **Mebendazole** may increase the effects of **Warfarin**, leading to an increased risk of bleeding. Regular monitoring of **INR (International Normalized Ratio)** is advised when these drugs are used together. - **Alcohol**: Although no major interactions are noted with **alcohol**, it is generally advised to avoid excessive alcohol consumption during treatment with **Mebendazole** to reduce the risk of liver damage. Patients should inform their healthcare provider of all medications, including over-the-counter drugs and supplements, to avoid potential drug interactions.

Pregnancy Category Note

Information not available

Adult Dose

For most **intestinal worm infections**, the typical adult dose of **Mebendazole** is as follows: - **Pinworm (Enterobiasis)**: **100 mg** as a single dose, which may be repeated after two weeks if reinfection occurs. - **Roundworm (Ascariasis)**: **100 mg** twice daily for **3 days**. - **Hookworm (Ancylostomiasis)**: **100 mg** twice daily for **3 days**. - **Whipworm (Trichuriasis)**: **100 mg** twice daily for **3 days**. The **dosage may vary** depending on the type of infection, so it is important for patients to follow their healthcare provider’s specific instructions.

Child Dose

For children, **Mebendazole** dosing depends on the age and type of infection: - **Children (over 2 years old)**: The typical dose is **100 mg** once a day for **3 days** for common infections like **pinworm**. - **For older children or higher weight**: The dose may be adjusted to **100 mg twice daily** for **3 days**, depending on the type of parasitic infection and the child’s health. Always consult a pediatrician before administering **Mebendazole** to children to ensure the correct dosage and avoid any potential risks.

Renal Dose

There are no specific dosage adjustments for **Mebendazole** in patients with **renal impairment**, as the drug is poorly absorbed and primarily acts in the intestines. However, patients with significant renal dysfunction should still be monitored for potential side effects or toxicity, especially if other medications are involved.

Administration

Information not available